Carbapenamase Producing Enterobacteriaceae: A Draining Concern
|
|
- Roberta Simmons
- 5 years ago
- Views:
Transcription
1 Carbapenamase Producing Enterobacteriaceae: A Draining Concern Heather Candon, B.Sc., M.Sc., MHM, CIC Lorraine Maze dit Mieusement, RN, MN, CIC Natasha Salt, B.Sc., B.A.Sc., CPHI (C), CIC
2 Introduction What is CPE? Risk factors associated with acquisition What s happening in Ontario Why Canadian hospitals should be concerned 1) Identification 2) Management 3) Mitigation 4) Prevention Take home messaging
3 CPE: What is it? Enterobacteriaceae - family of bacteria commonly found in human gastrointestinal tract. Sometimes these bacteria can spread outside the gut and cause serious infections, such as urinary tract infections, bloodstream infections, wound infections, and pneumonia. In rare instances can become resistant to a group of antibiotics called carbapenems, often antibiotics of last resort
4 Carbapenems the Big Guns ertapenem imipenem meropenem doripenem
5 Know your acronyms and your true Enemies
6 Gene Warfare CPE are Gram-negative Enterobacteriaceae (e.g., Klebsiella, E.coli) resistant to carbapenem class of antibiotics through a carbapenase enzyme Carbapenemase genes include KPC, NDM-1, IMP, VIM, OXA-48, NMC, VEB, PER, SME, GES Eg: Klebsiella pneumonia KPC or NDM-1 or VIM
7 Carbapenemases
8 How does a CPE patient present? Infection versus Colonization A patient with CPE can be either infected or colonized. Invasive infections 50% mortality rate
9 How do we deal in the hospital? CPE are usually transmitted from person to person, often via the hands of healthcare personnel or via contaminated medical equipment. Prevent transmission Hand hygiene Contact precautions Enhanced environmental cleaning
10 Risk Factors for CPE Transmission of CPE is increasingly reported in Canadian hospitals Risk factors for acquisition of CPE: Healthcare outside of Canada and/or travel to an Indian Subcontinent Antibiotic receipt Exposure to CPE colonized/infected patients Environmental sources (CPE-colonized sinks) Screening tools often capture healthcare outside of Canada and/or travel to an Indian Subcontinent in the last 12 months: Increasingly, positive patients have had no risk factors other than exposure to a Canadian healthcare facility
11 International travel is an important risk factor for being colonized or infected with resistant organisms (Laupland, J Infect 2008; Tängdén, Antimicrob Agents Chemother 2010) NDM-1 producing bacteria have been associated with admission to hospitals in south Asia (Kumarasamy, Lancet Infect Dis 2010) Medical Tourism
12 Ontario Yours to discover CPE
13 Source: Public Health Ontario Laboratories, Carbapenemase-producing Enterobacteriaceae database, extracted by Public Health Ontario [2016/02/29]
14 Source: Public Health Ontario Laboratories, Carbapenemase-producing Enterobacteriaceae database, extracted by Public Health Ontario [2016/02/29]
15 8/70 had no foreign hospitalization or travel history 5 with previous hospitalization in Canada Source: Public Health Ontario Laboratories, Carbapenemase-producing Enterobacteriaceae database, extracted by Public Health Ontario [2016/02/29]
16
17
18
19
20 Identification: Where is CPE coming from?
21
22 Carbapenem Resistance Challenges in Management Easy plasmid transmission Widen the net for screening and detection (?) Few treatment options Lack of data re: effective infection control Environmental contamination may be common, unrecognized
23 Identification: Admission Screening Questions at Triage
24 Identification: Types of CPE Positive Specimens for First Detection n=23 n=26 n=16 More admission questions = quicker detection via screening specimens rather than clinical isolates
25 Management: CPE Positive Patient Facility Patient Management Room Management (excluding discharge) Unit Screening Contact Tracing 1 Private room Contact precautions Dedicated equipment Sign posted at sink to prevent dumping AHP in drains weekly Prevalence screen after first nosocomial case identified Flag patient and environmental exposures Screen via rectal swabs and urine cultures at 0, 7, 14, and 21 days 2 Private room Contact precautions Dedicated equipment Twice daily room cleaning Weekly point prevalence while patient admitted Weekly point prevalence x 3 weeks postdischarge Flag patient and environmental exposures Screen via rectal swabs at 0, 7, 14, and 21 days 3 Accelerated Hydrogen Peroxide (AHP) Private room Contact precautions Dedicated equipment Basin-less care Sign posted at sink to prevent dumping AHP in drains weekly Twice daily room cleaning Prevalence screen after first nosocomial case identified Flag patient and environmental exposures Screen via rectal swabs and urine cultures at 0, 7, 14, and 21 days
26 Multi-facility comparison Facility A Facility B Facility C Facility D Facility E Facility F Facility G CPE Cleaning while patient is occupying the room Twice a day using bleach, pour toilet bowl bleach cleaner down all sinks daily. Twice a day using bleach Double clean along with sink with Accelerated Hydrogen peroxide (AHP) Twice daily with AHP, sinks and washroom clean AHP gel Regular daily cleaning; AHP gel poured down the sink twice a week; sinks closed in some ICU settings Twice daily CPE Terminal Clean Protocol Terminal clean x2 with bleach Terminal clean x2 using bleach. Terminal clean x 2 with AHP Terminal clean x2 with AHP, sinks and washroom clean with AHP Gel. Terminal clean x2 with bleach Terminal clean x2 with AHP and AHP gel down the sink Terminal clean x2 (no wall washing in room necessary but walls have to be done in bathroom, curtain need changing) Sink cleaning protocol Bleach toilet bowl cleaner, steam Bleach (still sorting out their cleaning and swabbing protocol) Steam clean AHP Gel bleach toilet bowl cleaner, steam AHP gel AHP gel Do you swab the sink? If yes, who swabs it? Yes, ICP Yes, ICP Yes, mostly by ICP but sometimes by Housekeeping No, only if there s an outbreak Yes, ICP Yes, ICP Yes, ICP Only at our 1 campus as we had some CPE transmission. If yes, when? (pre/post cleaning) Pre-cleaning Pre and post Pre-cleaning N/A Pre-cleaning Post cleaning Post cleaning Do you close the sink pending result? No Yes Yes both sink and room (usually 48 hours) N/A Yes Yes, if it was used while the CPE positive patient was there No Do you repeat the sink swab? No If positive, or if pt in the room/ward/unit positive, repeat swabs every month. 2 and 6 weeks post N/A 2 weeks post 1 week later If swab is positive, what do you do? No experience with this Cleaning done by maintenance/evs remove P trap, remove buildup, scrub with a brush, use AHP gel If positive, try to clean the sink again (double-clean and steam, pouring liquids, etc) we haven t been too successful in getting rid of CPE once in the sink, so generally remove and replace N/A If positive, re-clean with AHP gel may have to remove the P-trap if still positive despite multiple cleaning No experience with this. Likely repeat disinfection and flag patient as a contact and swab Does your sink management differ from ICU and ward No No No No Yes (depending on setting: ICU, Burn and Ward) No
27 Management: CPE Discharge Process
28 Biofilm Formation
29 Mitigation: CPE Positive Discharge Process Sink Cultures Drain and overflow hole (if applicable) cultured post discharge If negative, consider collecting repeat cultures (?) Aerators, faucets, shower heads/drains, toilets, etc?
30 Mitigation: CPE Positive Discharge Process Drain tool
31 Mitigation: CPE Positive Discharge Process
32 Mitigation: CPE Positive Discharge Process
33 Environmental Swabs for CPE 16% conversion 13% conversion
34 Mitigation: CPE Positive Plumbing P-trap
35 How did the drains become positive? Environmental scan of body fluid dumping
36 Hand Hygiene Sink Bath water Body fluids IV fluids Please discard all fluids in the soiled utility room
37 Prevention: Maintenance of Hospital Drains Ongoing drain cleaning/maintenance Range from none to yearly Update to CSA Plumbing Guidelines for Healthcare Facilities Liquid drain cleaner, foam/liquid, steam Focus in high risk areas i.e., ICUs
38 Ongoing plumbing replacement not feasible in long term Sink design Drain design Anti-biofilm claims Water-free patient care Moving Forward
39 Author, Journal, Date Setting, Country Microorgani sm Reservoir Plumbing action Starlander et al., JHI 2012 ICU, Sweden ESBL Klebsiella pneumoniae Four patients epi-linked to the same room over 7-months Hand hygiene sink used for waste disposal Sink replacement Drains tested quarterly for 1 year - negative Unclear how far back plumbing replaced No mention of preventative maintenance Leitner et al., ASM 2015 ICU, hematology, Austria CPE Klebsiella oxytoca Fifteen patients over 2-years Sinks, medication room sink and shower drain Sink replacement - shower? Unclear how far back plumbing replaced No mention of preventative maintenance Palmore et al., HE 2013 ICU, Maryland CPE Klebsiella pneumoniae Eighteen patients over 6-months Removed sinks and cleaned No plumbing replacement PM - Spray bleach down daily Kotsanas et al., MJA 2013 ICU, Australia CPE Serratia marcescens Ten patients over 3-years Hand hygiene sink used for waste disposal Brush, bleach, steam - unsuccessful Sink replacement Unclear how far back plumbing replaced No mention of preventative maintenance Lowe et al., EID 2012 ICU, Stepdown unit, CCU, Canada ESBL Klebsiella oxytoca Sixty-six patients over 5 years Hand hygiene sink used for waste disposal Brush, disinfection, standing - unsuccessful Sink replacement Plumbing to the wall changed (?) No mention of preventative maintenance Hota et al., ICHE 2009 ICU, Canada MDR- Pseudomona s Thirty-six patients over 1.5 years Hand hygiene sink used for waste disposal AHP - unsuccessful Sink replacement Sink traps No mention of preventative maintenance Tofteland et al., PLoS 2013 ICU, Norway CPE Klebsiella pneumoniae Seven patients over 3-years Hand hygiene sink used for waste disposal Sink replacement Sink traps No mention of preventative maintenance Lowe et al., ICHE 2013 Canada CPE Klebsiella pneumoniae Seven patients over 15 months Hand hygiene sink used for waste disposal Disinfection - unsuccessful Sink replacement Sink traps No mention of preventative maintenance
40 Take Home Messages Contamination of sinks/drains with CPE is an emerging issue The environment may be a possible source of transmission Improper disposal of body fluids in sinks likely contributes significantly to sink/drain contamination The appropriate best practices approach for managing CPE positive drains and preventative maintenance are unknown Drains and sinks for healthcare should be chosen based on a design that minimizes risk to patients We should collectively push manufacturers to develop safer equipment The necessity of sinks in patient care areas should be weighed against potential harm to the patient Future research is needed to establish guidelines
41 Questions? Heather Lorraine Maze dit Mieusement: Natasha
TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)
TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO) Reference Number POL- IC/1082/14 Version 1.2.0 Status Final Author: Helen Forrest
More informationAssessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE)
Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE) CPE Expert Group National Guidance Document, Version 1.0 Scope of this Guidance This guidance
More informationGuidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) 2012 CRE Toolkit
Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) 2012 CRE Toolkit National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Guidance for
More informationCARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT
CARBAPENEMASE PRODUCING ENTEROBACTERICAE (CPE): COMMUNITY TOOLKIT Rick Catlin 04/04/18 CPE Carbapenemase producing enterobactericae Gut bacteria (enterobactericae) that have developed resistance to multiple
More informationEnterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion
Preventing the Spread of Carbapenemresistant Enterobacteriaceae in LTCFs Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion March 29, 2016 Preventing the Spread of Carbapenemresistant
More informationEarly detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0
Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing
More informationCarbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or
More informationKristi Felix RN, BSN, CRRN, CIC, FAPIC Infection Prevention Coordinator Madonna Rehabilitation Hospitals
Kristi Felix RN, BSN, CRRN, CIC, FAPIC Infection Prevention Coordinator Madonna Rehabilitation Hospitals Resident safety-priority for staff and for CMS Providing care in a homelike environment but still
More informationYou have questions about CPE and CRE? Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team.
You have questions about CPE and CRE? Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. May 2017 This sheet gives answers to some common questions that patients
More informationInfection Prevention and Control. Carbapenemase Producing Enterobacteriaceae (CPE)
Infection Prevention and Control Carbapenemase Producing Enterobacteriaceae (CPE) IPCT CPE Policy V4 May 2018 Policy Title: Executive Summary: Carbapenemase Producing Enterobacteriaceae (CPE) This policy
More informationCarbapenemase-producing Enterobacteriaceae (CPE) in HSE acute hospitals in Ireland monthly report December 2017
Carbapenemase-producing Enterobacteriaceae (CPE) in HSE acute hospitals in Ireland monthly report December 2017 The terms carbapenem resistant Enterobacteriaceae (CRE) and carbapenemase-producing Enterobacteriaceae
More informationInfection Control Prevention Strategies. For Clinical Personnel
Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling
More informationHealthcare Antibiotic Resistance Prevalence DC (HARP-DC)
Healthcare Antibiotic Resistance Prevalence DC (HARP-DC) Jacqueline Reuben, MHS Center for Policy, Planning and Evaluation District of Columbia Department of Health October 29, 2016 Nothing to Disclose
More informationCarbapenemase Producing Coliforms (CPC)
Carbapenemase Producing Coliforms (CPC) Corporate Division Patient Information Leaflet What is CPC? CPC stands for Carbapenemase producing Coliforms. Coliforms are bacteria that normally live in the gut.
More informationInfection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy
Infection Prevention and Control Carbapenemase producing Enterobacteriaceae (CPE) Policy East Cheshire NHS Trust Infection Prevention and Control CPE V3 March 2016 1 Policy Title: Executive Summary: Carbapenemase
More informationCRE and XDRO for Long Term Care Facilities. May 28, 2014
CRE and XDRO for Long Term Care Facilities May 28, 2014 Featured Presenters Deb Burdsall, MSN, RN-BC, CIC Infection Preventionist Lutheran Home/Lutheran Life Communities William Trick, M.D. Director, Collaborative
More informationCENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
CENTRAL MANCHESTER UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Agenda Item 9.1 Report of: Paper prepared by: Cheryl Lenney - Chief Nurse Consultant Nurse Infection Prevention and Control Julie Cawthorne
More informationThe Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA
The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA Marcia Patrick, RN, MSN, CIC Infection Control Director MultiCare Health System Tacoma, WA APIC/BD MRSA Presentation
More informationVancomycin-Resistant Enterococcus (VRE)
Approved by: Vancomycin-Resistant Enterococcus (VRE) Vice President & Chief Medical Officer Corporate Policy & Procedures Manual VI-40 Date Approved July 14, 2016 August 12, 2016 Next Review (3 years from
More informationInfection Control Prevention Strategies. For Clinical Personnel
Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling
More informationPreventing Further Spread of CPE
Provisional Guidance relating to CPE for General Practice. May 26 2017. Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. What is CPE (Carbapenemase Producing
More informationNOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION
NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION DR AHMAD SHALTUT OTHMAN JAB ANESTESIOLOGI & RAWATAN RAPI HOSP SULTANAH BAHIYAH ALOR SETAR, KEDAH Nosocomial infection Nosocomial or hospital
More informationHEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE
HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE Author: Jenny Boyce, Lead Infection Prevention & Control Nurse Approved by and date: March 2016 Any other linked ICP 000 - Infection Prevention
More informationSurveillance Protocol for Carbapenemase- Producing Organisms (CPO) in British Columbia
Surveillance Protocol for Carbapenemase- Producing Organisms (CPO) in British Columbia December 2017 Contacts: Dr. Linda Hoang Program Head, Public Health Advanced Bacteriology & Mycology BCCDC Public
More informationApproval Signature: Date of Approval: December 6, 2007 Review Date:
Personal Care Home/Long Term Care Facility Infection Prevention and Control Program Operational Directive Management of Methicillin-Resistant Staphylococcus Aureus (MRSA) Approval Signature: Supercedes:
More informationCarbapenemase producing. Carbapenem Resistant Enterobacteriaceae. (CRE) in Critical Care Units in Ireland: A National Pilot Study June 2011
Carbapenemase producing Carbapenem Resistant Enterobacteriaceae (CRE) in Critical Care Units in Ireland: A National Pilot Study June 2011 National Report September 2011 CRE in Critical Care Units in Ireland
More informationMRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke
MRSA situations in Holland: What is behind the success? ICP, VieCuri Medical Centre Venlo, The Netherlands Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com INFECTION CONTROL HISTORY
More informationMulti-resistant bacteria and spinal cord injury - an insight into practices throughout Europe
Multi-resistant bacteria and spinal cord injury - an insight into practices throughout Europe Authors: Gunilla Åhrén, 1 st executive of ESCIF, Jane Horsewell, President of ESCIF Background The burden of
More informationInfection Control Care Plan for a patient with confirmed/ suspected Active Pulmonary Tuberculosis. Patient Demographic / Label
Patient Demographic / Label Infection Control Care Plan for a patient with Statement: This Care Plan should be used with patients who are suspected of or are known to have active pulmonary tuberculosis.
More informationAlert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA
Infection Prevention and Control Assurance - Standard Operating Procedure 22 (IPC SOP 22) Alert Organisms Multi-Resistant Gram Negative Bacteria (MR-GNB) excluding MRSA Why we have a procedure? To ensure
More informationNosocomial Infection in a Teaching Hospital in Thailand
Nosocomial Infection in a Teaching Hospital in Thailand Somsak Lolekha, M.D., Ph.D.,* Banchong Ratanaubol R.N.** and Pranom Manu R.N.** (*Department of Pediatrics; **Department of Nursing, Faculty of Medicine
More informationInfection Prevention Isolation Precautions Toolkit
Infection Prevention Isolation Precautions Toolkit The toolkit provides: Link(s) to revised Isolation Policy on The Point Link to ICON training video and key changes to policy (NEW) Quick Review Chart
More informationISOLATION TABLE OF CONTENTS STANDARD PRECAUTIONS... 2 CONTACT PRECAUTIONS... 4 DROPLET PRECAUTIONS... 6 ISOLATION PROCEDURES... 7
ISOLATION TABLE OF CONTENTS STANDARD PRECAUTIONS... 2 BARRIERS INDICATED IN STANDARD PRECAUTIONS... 2 PERSONAL PROTECTIVE EQUIPMENT... 3 CONTACT PRECAUTIONS... 4 RESIDENT PLACEMENT... 4 RESIDENT TRANSPORT...
More informationMRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of
MRSA INFORMATION LEAFLET for patients and relatives WHAT DOES MRSA STAND FOR? Meticillin Resistant Staphylococcus aureus. WHAT IS MRSA? Staphylococcus aureus is a germ that is commonly found both in hospital
More informationGuidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015
Guidelines for the Management of C. difficile Infections in Healthcare Settings Saskatchewan Infection Prevention and Control Program November 2015 Agenda What is C. difficile infection (CDI)? How do we
More informationInfection Prevention and Control
Infection Prevention and Control Infection Control in the Healthcare Setting Chain of Infection Hand Hygiene Hospital Acquired Infections Isolation Exposures Tuberculosis Chain of Infection Most Common
More informationINFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM
INFECTION CONTROL EDUCATION PROGRAM Isolation Precautions Isolating the disease not the patient The Purpose is To protect compromised patient from environment To prevent the spread of communicable diseases.
More informationNHS GREATER GLASGOW & CLYDE STANDARD OPERATING PROCEDURE (SOP)
This SOP applies to all staff employed by NHS Greater Glasgow & Clyde and locum staff on fixed term contracts and volunteer staff. SOP Objective To minimise the risk of Pseudomonas aeruginosa infection
More informationState of the State Address on HAI Prevention Activities
State of the State Address on HAI Prevention Activities Disclaimer/Conflict of Interest I have no disclaimers or conflicts of interest to report Objectives Identify priority action areas and components
More informationProcedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE)
SH CP 177 Procedure for the Management and Control of Carbapenemase-producing Enterobacteriaceae (CPE) Infection Prevention and Control Policy: Appendix 21 Version 2 Summary: Defines the actions and management,
More informationSECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)
SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication
More informationGuideline with MDRO or C-Diff Patient Age Group: ( ) N/A (x ) All Ages ( ) Newborns ( ) Pediatric ( ) Adult
Applies To: UNM Hospitals Responsible Department: Epidemiology Revised: 7/2012 Title: Management of Patients Infected or Colonized Guideline with MDRO or C-Diff Patient Age Group: ( ) N/A (x ) All Ages
More informationPatient & Family Guide. VRE (Vancomycinresistant. Enterococcus)
Patient & Family Guide VRE (Vancomycinresistant Enterococcus) 2017 www.nshealth.ca VRE (Vancomycin-resistant Enterococcus) What is VRE? Enterococci (plural of enterococcus) are bacteria that are commonly
More informationInfection Control Policy and Procedure Manual. Post-Anesthesia Care Unit (Recovery Room) Page 1 of 6
(Recovery Room) Page 1 of 6 Purpose: The purpose of this policy is to establish infection prevention guidelines to prevent or minimize transmission of infections in the. Policy: All personnel will adhere
More informationClostridium difficile
Clostridium difficile Michelle Luscombe & Karly Herberholz Hagel 5/14/2012 1 Outline What is clostridium difficile infection (CDI)? Symptoms & Complications Risk Factors Transmission Prevention and Control
More informationGuidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings
Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings : Program Goal Improve personnel safety in the healthcare environment through appropriate use of PPE. :
More informationOther (please specify): Note: This document has been assessed for any equality, diversity or human rights implications
Post holder responsible for Procedural Document Author of Policy Division/ Department responsible for Procedural Document Contact details Nicola Colborne, Infection Prevention and Control Nurse Specialist
More informationPrevention and Control of Carbapenem Resistant Enterobacteriaceae Infections
01.41 - Prevention and Control of Carbapenem Resistant Purpose To prevent healthcare-associated infections in patients caused by carbapenem-resistant Enterobacteriaceae (CRE). Audience All healthcare workers
More informationObjectives. Industry Landscape. Infection Prevention and Control Changes, Updates and Quality Results!
Infection Prevention and Control Changes, Updates and Quality Results! Sue LaGrange, RN, BSN, NHA, CDONA, FACDONA, CIMT Director of Education Pathway Health 1 Objectives 1.Describe the recent industry
More informationPrevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015
Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in
More information06/09/2017. What will I talk about today? Sharing lessons learned from a CPE outbreak UL Hospitals Barbara Slevin, Group ADON IPC
Sharing lessons learned from a CPE outbreak UL Hospitals Barbara Slevin, Group ADON IPC 2017 What will I talk about today? Overview Background UL Hospitals experience Quality Improvement measures Ongoing
More informationSection J - Management of Patients with Multi Resistant Organisms:
Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended
More informationSection J - Management of Patients with Multi Resistant Organisms:
Section J - Management of Patients with Multi Resistant Organisms: Carbapenemase-Producing Enterobacteriaceae (CPE) Vancomycin-Resistant Enterococci (VRE) Penicillin-Resistant Pneumococci (PRP) Extended
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here May 9, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Mute your phone during the presentation
More informationPatient and Visitor Involvement: The Hand Hygiene Missing Link?
Patient and Visitor Involvement: The Hand Hygiene Missing Link? Jim Gauthier, MLT, CIC CHICA-Canada Past President Providence Care, Kingston, ON CPSI April 2013 1 Objectives Review some of our issues with
More informationRequirements for Screening of Patients for Carbapenemase-Producing Enterobacteriales (CPE) 1 in the Acute Hospital Sector CPE Expert Group
Requirements for Screening of Patients for Carbapenemase-Producing Enterobacteriales (CPE) 1 in the Acute Hospital Sector CPE Expert Group POLICY DOCUMENT These guidelines are aimed at all health professionals
More informationThe most up to date version of this policy can be viewed at the following website:
Page Page 1 of 6 Policy Objective To ensure that HCWs are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical conditions
More informationWashable Keyboards Helps Hospitals Tackle Cross Contamination
Washable Keyboards Helps Hospitals Tackle Cross Contamination TABLE OF CONTENTS Washable Keyboards Helps Hospitals Tackle Cross-Contamination... 3 Testing Positive for Pathogens... 3 Neglecting Keyboards...
More informationWater and Sanitation in Hospitals and Healthcare: A South African and International perspective Mudau LS. Tshwane University of Technology
Corporate Affairs and Marketing (CA&M) Brand and Event Management Water and Sanitation in Hospitals and Healthcare: A South African and International perspective Mudau LS Tshwane University of Technology
More informationCarbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO)
Carbapenemase-Producing Enterobacteriaceae (CPE) and Carbapenemase-Producing Organisms (CPO) Information for patients and visitors This leaflet explains how we test for, treat and prevent the spread of
More informationINFECTION PREVENTION AND CONTROL. Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy
INFECTION PREVENTION AND CONTROL Multi- Resistant Gram Negative Bacilli Including E.coli and Acinetobacter Species Policy IPCT Multi-Resistant Gram Negative Bacilli Policy, V4, Dec 16 Page 1 Policy Title:
More informationInfection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases
Infection Prevention Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases to yourself, family members,
More informationHow to Add an Annual Facility Survey
Add an Annual Facility Survey https://nhsn.cdc.gov/nhsndemo/help/patient_safety_component/how_to/add_an_annual... Page 1 of 1 10/9/2017 Show Patient Safety Component > How To > Facility > Add an Annual
More informationPolicy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)
Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance
More informationPolicy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.
Page Page 1 of 6 Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection. 1 Responsibilities 2 General information on RSV 3
More informationRQHR Outbreak 2013/2014 Review & Lessons Learned
RQHR Outbreak 2013/2014 Review & Lessons Learned 6F VRE Timeline Pre-Outbreak: March 21 April 15, 2013 an increase in new VRE cases was seen on 6F 8 new VRE colonized patients, 7 of which were documented
More informationBEHAVIORAL HEALTH & LTC. Mary Ann Kellar, RN, MA, CHES, IC March 2011
BEHAVIORAL HEALTH & LTC Mary Ann Kellar, RN, MA, CHES, IC March 2011 CDC Isolation Guidelines-adapting to special environments MDRO s CMS-F 441 C.difficile Norovirus Federal (CMS), State & Joint Commission
More informationPersonal Hygiene & Protective Equipment. NEO111 M. Jorgenson, RN BSN
Personal Hygiene & Protective Equipment NEO111 M. Jorgenson, RN BSN Hand Hygiene the single most effective way to help prevent the spread of infections agents. (CDC, 2002.) Consistency & Compliancy 50%
More informationOregon Health & Science University Department of Surgery Standard Precautions Policy
Standard Precautions Policy 1. Policy Standard Precautions are to be followed by all employees for all patients within and entering the OHSU system. Standard Precautions are designed to reduce the risk
More informationHealthcare-Associated Infections
Healthcare-Associated Infections A healthcare crisis requiring European leadership Healthcare-associated infections (HAIs - also referred to as nosocomial infections) are defined as an infection occurring
More informationIC CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017
IC.04.03 CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017 Standard In addition to Routine Practices, Contact Precautions or Contact Plus Precautions will be used for patients known or suspected to have
More informationA guide for patients and visitors MRSA. A guide for patients and visitors
MRSA A guide for patients and visitors 1 The purpose of this leaflet is to provide information to you and your family about MRSA. The word bacteria has been used in this leaflet to describe commonly used
More informationClostridium difficile Infection (CDI)
Approved by: Clostridium difficile Infection (CDI) Vice President and Chief Medical Officer Corporate Policy & Procedures Manual VI-8 Date Approved August 22, 2016 September 16, 2016 Next Review (3 years
More informationChapter 10. medical and Surgical Asepsis. safe, effective Care environment. Practices that Promote Medical Asepsis
chapter 10 Unit 1 Section Chapter 10 safe, effective Care environment safety and Infection Control medical and Surgical Asepsis Overview Asepsis The absence of illness-producing micro-organisms. Asepsis
More informationIdentify patients with Active Surveillance Cultures (ASC)
MRSA CHANGE STRATEGIES The following tables include change strategies proven to be effective in healthcare settings. Implementing these changes through current or new processes may result in reducing healthcare
More informationDirect cause of 5,000 deaths per year
HOSPITAL ACQUIRED (NOSOCOMIAL) INFECTION Policies MRSA Policy Meningitis Policy Blood and body fluid Exposure Policy Disinfection Policy Glove Policy Tuberculosis Policy Isolation Policy DEFINITION: ANY
More informationIsolation Care of Patients in Isolation due to Infection or Disease
Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection
More informationInfection Prevention, Control & Immunizations
Infection Control: This facility task must be used to investigate compliance at F880, F881, and F883. For the purpose of this task, staff includes employees, consultants, contractors, volunteers, and others
More informationPrairie North Regional Health Authority: Hospital-acquired infections
Prairie North Regional Health Authority: Hospital-acquired infections Main points... 308 Introduction... 309 Background the risk of hospital-acquired infections... 309 Audit objective, scope, criteria,
More informationInfection Control and Prevention On-site Review Tool Hospitals
Infection Control and Prevention On-site Review Tool Hospitals Section 1.C. Systems to Prevent Transmission of MDROs Ask these questions of the IP. 1.C.2 Systems are in place to designate patients known
More informationBurn Intensive Care Unit
Purpose The burn wound is especially susceptible to microbial invasion because of loss of the protective integument and the presence of devitalized tissue. Reduction of the risk of infection is of utmost
More informationMinistry of Labour Occupational Health & Safety and Infection Prevention & Control
Ministry of Labour Occupational Health & Safety and Infection Prevention & Control Presentation to Northern Ontario ICN September 23, 2011 Denise Madsen, RN, BScN, CIC Infection Control Consultant Northern
More informationInfection Control, Still the Most Commonly Cited Tag in Texas
July 2016 Commitment to Care Quality Topic Infection Control, Still the Most Commonly Cited Tag in Texas F -441 continues to show up on the list of top 10 deficiencies every quarter here in Texas. During
More informationOrientation Program for Infection Control Professionals
Orientation Program for Infection Control Professionals Module 1: Introduction and Four-Week Schedule Table of Contents Module 1: Introduction... 2 Note to Managers... 2 IPC Orientation Program... 3 Four-Week
More informationInfection Control Care Plan for a patient with Group A Streptococcus
Infection Control Care Plan for a patient with Group A Streptococcus Statement: This Care Plan should be used with patients who are suspected of or are known to have Group A Streptococcal infection. This
More informationInfection Control Care Plan. Patient Demographic / label. Hospital: Ward:
Patient Demographic / label Infection Control Care Plan for a patient with loose stools of unknown origin Statement: This care plan should be used with patients who have loose stools of unknown origin.
More informationClostridium difficile Algorithms for Long-term Care
Clostridium difficile lgorithms for Long-term Care 1 Early Recognition and esting 2 Contact Precautions 3 Room Placement 3.1 Identifying Lower Risk Roommates 4 Environmental Cleaning and Disinfection 5
More informationInfection Prevention and Control for Phlebotomy
Page 1 of 10 POLICY STATEMENT: It is Sunnybrook s Policy to prevent the spread of infection within the health care institution from patient to patient, patient to staff, staff to patient by: a) providing
More informationHospital-Acquired Infections in Intensive Care Unit Patients: An Overview with Emphasis on Epidemics
Hospital-Acquired Infections in Intensive Care Unit Patients: An Overview with Emphasis on Epidemics Richard R Wenzel, MD, Robert L. Thompson, MD, Sandra M. Landry, RN, Brenda S. Russell, RN, Patti J.
More informationPolicy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.
Page Page 1 of 9 Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection. This policy applies to all staff employed by NHS Greater
More informationClostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative
Patient information Clostridium difficile GDH positive (Glutamate Dehydrogenase) toxin negative i Important information for all patients. Golden Jubilee National Hospital Agamemnon Street Clydebank, G81
More informationWHEREAS, Ebola Virus Disease (EVD) is a rare and potentially deadly disease caused
STATE OF NEW YORK : DEPARTMENT OF HEALTH --------------------------------------------------------------------------X IN THE MATTER OF THE PREVENTION AND CONTROL OF EBOLA VIRUS DISEASE ORDER FOR SUMMARY
More informationRapid Response Report:
Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé Rapid Response Report: Systematic Review CADTH September 2012 Screening, Isolation,
More informationSelf-Assessment Summary Report 2017 Accreditation
FLA LEEND: UNMET MET ONOIN R 5.2 Team members, clients and families, and volunteers are engaged when developing the multi-faceted approach for IPC. R 1.3 The resources needed to support the IPC program
More informationAssessment Tool Environmental Services
POLICIES AND PROCEDURES The following policies have been developed, implemented and staff are aware of their location: 1. Infection Prevention and Control (IP&C) policy or manual 2. Environmental Services
More informationPARTNERING TO CREATE A CLEANER, HEALTHIER AND SAFER ENVIRONMENT FOR SENIORS
PARTNERING TO CREATE A CLEANER, HEALTHIER AND SAFER ENVIRONMENT FOR SENIORS A sustainable cleaning program designed with residents, custodians and staff in mind! Proven Strategies for a Cleaner, Healthier
More informationCleaning policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope Definitions...
Cleaning policy Board library reference Document author Assured by Review cycle P005 Head of Estates and Facilities Quality and Standards Committee 3 years This document is version controlled. The master
More informationToolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae in Scottish acute settings
Toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae in Scottish acute settings Version: 1.0 Date: May 2016 Owner/Author: HPS Review Date: May 2017 1 Document
More informationPIDAC: Best Practices for Environmental Cleaning. Francine Paquette Team Lead - IPAC West Regional Office
PIDAC: Best Practices for Environmental Cleaning Francine Paquette Team Lead - IPAC West Regional Office PIDAC Best Practices for Environmental Cleaning COMING SOON! 2 For today: Why revise? What s new?
More informationInvestigation of a Clostridium difficile associated disease outbreak at Nanaimo General Regional Hospital August 2008.
Investigation of a Clostridium difficile associated disease outbreak at Nanaimo General Regional Hospital August 2008. Executive summary NGRH experienced an outbreak of Clostridium difficile associated
More information